The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...
Are you like me, a member of a rotten club neither of us wants to be in? That is the chronic disease club — those of us who have some kind of underlying illness that, while it might vary in its ...